Century Therapeutics reports nonclinical data to support CNTY-813 clinical trial progress
Century Therapeutics presented updated nonclinical data for its CNTY-813 islet therapy at EASD, demonstrating efficacy and supporting the planned IND submission for Q4 2026 and clinical launch.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed